This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mueller, T. Articles by Schmoll, H.-J. Search for Related Content PubMed PubMed Citation Articles by Mueller, T. Articles by Schmoll, H.-J.

Failure of Activation of Caspase-9 Induces a Higher Threshold for Apoptosis and Cisplatin Resistance in Testicular Cancer¹

Department of Hematology/Oncology, Martin-Luther-University of Halle-Wittenberg, 06120 Halle, Germany

Testicular germ cell cancer is one of the very few cancers that are highly sensitive to and curable by cisplatin-based chemotherapy even in an advanced stage. However, in a few cases resistance to cisplatin occurs and patients subsequently die from progressive disease. The molecular basis for this resistance remains to be determined. Using two cisplatin-sensitive (2102EP and H12.1) and one cisplatin-resistant human testicular germ cell cancer cell line (1411HP), we investigated molecular mechanisms in the induction of apoptosis after cisplatin-treatment focusing on the cleavage and activation of caspase-2, caspase-3, caspase-7, caspase-8, and caspase-9.

The cell line 1411HP showed a 3.3-fold cisplatin resistance when compared with the sensitive cell lines 2102EP and H12.1 by IC₉₀s, which was treatment schedule independent (2- or 24-h incubation). Cisplatin resistance was associated with substantially decreased apoptosis in vitro and in derived nude mice xenografts as determined by Apo 2.7 detection, DNA-laddering, immunohistochemistry of active caspase-3, and terminal deoxynucleotidyl transferase-mediated nick end labeling assay. Total DNA platination as assessed by ELISA after cisplatin treatment in equimolar doses did not differ between cisplatin-resistant or -sensitive cells. In separate analysis of cells of early and late apoptotic stages, initiation of cisplatin-induced apoptosis appeared to be rather mediated by caspase-9 than by caspase-8. Resistant 1411HP cells failed to activate caspase-9 during the induction of apoptosis after cisplatin treatment at the IC₉₀ dose. Interestingly, inhibition of caspase-9 in sensitive H12.1 almost completely blocked apoptosis and induced cisplatin resistance to the same extent as in 1411HP so that apoptosis could only be induced by 3.3-fold higher cisplatin doses. Furthermore, in caspase-9 blocked cells, initiation of apoptosis occurred in a caspase-9 independent manner accompanied by activation of caspase-2 and caspase-3, which are intrinsic characteristics of resistant 1411HP cells. Failure of caspase-9 activation and cisplatin resistance was independent of the expression of p53, Bcl-2 family proteins, Fas receptor, and Fas ligand. In conclusion, failure of activation of the caspase-9 pathway induces a higher cellular threshold for cisplatin-mediated induction of apoptosis in testicular cancer cells. However, this higher threshold can be overcome by higher cisplatin doses, conceivably by using an alternate, caspase-9-independent apoptotic pathway. This supports the current clinical strategy of high-dose chemotherapy in patients with chemorefractory germ cell tumors. However, additional defining and eventually targeting the exact molecular mechanism blocking caspase-9 activation might lead to more selective therapeutic approaches to overcome cisplatin resistance in germ cell cancer.

This article has been cited by other articles:

				J. Houldsworth, J. E. Korkola, G. J. Bosl, and R. S. K. Chaganti Biology and Genetics of Adult Male Germ Cell Tumors J. Clin. Oncol., December 10, 2006; 24(35): 5512 - 5518. [Abstract] [Full Text] [PDF]

				L. P. Mueller, J. Luetzkendorf, T. Mueller, K. Reichelt, H. Simon, and H.-J. Schmoll Presence of Mesenchymal Stem Cells in Human Bone Marrow After Exposure to Chemotherapy: Evidence of Resistance to Apoptosis Induction Stem Cells, December 1, 2006; 24(12): 2753 - 2765. [Abstract] [Full Text] [PDF]

				L. J. Cobb, D. A. M. Salih, I. Gonzalez, G. Tripathi, E. J. Carter, F. Lovett, C. Holding, and J. M. Pell Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function J. Cell Sci., May 1, 2004; 117(9): 1737 - 1746. [Abstract] [Full Text] [PDF]

				T. M. Said, U. Paasch, H.-J. Glander, and A. Agarwal Role of caspases in male infertility Hum. Reprod. Update, January 1, 2004; 10(1): 39 - 51. [Abstract] [Full Text] [PDF]

				P. A. Nguewa, M. A. Fuertes, C. Alonso, and J. M. Perez Pharmacological Modulation of Poly(ADP-ribose) Polymerase-Mediated Cell Death: Exploitation in Cancer Chemotherapy Mol. Pharmacol., November 1, 2003; 64(5): 1007 - 1014. [Full Text] [PDF]

				L. Wall, F. Burke, C. Barton, J. Smyth, and F. Balkwill IFN-{gamma} Induces Apoptosis in Ovarian Cancer Cells in Vivo and in Vitro Clin. Cancer Res., July 1, 2003; 9(7): 2487 - 2496. [Abstract] [Full Text] [PDF]

				S. Ceruti, E. Beltrami, P. Matarrese, A. Mazzola, F. Cattabeni, W. Malorni, and M. P. Abbracchio A Key Role for Caspase-2 and Caspase-3 in the Apoptosis Induced by 2-Chloro-2'-deoxy-adenosine (Cladribine) and 2-Chloro-adenosine in Human Astrocytoma Cells Mol. Pharmacol., June 1, 2003; 63(6): 1437 - 1447. [Abstract] [Full Text] [PDF]